GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Research & Development

OKUR (OnKure Therapeutics) Research & Development : $13.33 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. OnKure Therapeutics's Research & Development for the three months ended in Sep. 2024 was $0.90 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $13.33 Mil.

OnKure Therapeutics Research & Development Historical Data

The historical data trend for OnKure Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Research & Development Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23
Research & Development
25.86 32.12

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial 13.62 -6.89 8.57 10.75 0.90

OnKure Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OnKure Therapeutics  (NAS:OKUR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

OnKure Therapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

OnKure Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Research & Development
Comparable Companies
CAMP LCTX OSTX ABOS CABA LPTX CSBR INMB MIST XBIT VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
Website
https://www.onkuretherapeutics.com
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.